Have a personal or library account? Click to login
Scutellarin mitigates LPS-ATP-induced cardiomyocyte pyroptosis through the inhibition of the NLRP3/caspase-1/GSDMD signalling pathway Cover

Scutellarin mitigates LPS-ATP-induced cardiomyocyte pyroptosis through the inhibition of the NLRP3/caspase-1/GSDMD signalling pathway

Acta Pharmaceutica
Volume 75 (2025): Issue 3 (September 2025)
By:
Open Access
|Oct 2025

References

  1. S. Toldo and A. Abbate, The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases, <em>Nat. Rev. Cardiol</em>. <bold>21</bold> (2024) 219–237; <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1038/s41569-023-00946-3" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1038/s41569-023-00946-3</a>">https://doi.org/10.1038/s41569-023-00946-3</ext-link>
    Search in Google ScholarBack to article
  2. S. Toldo, E. Mezzaroma, L. F. Buckley, N. Potere, M. Di Nisio, G. Biondi-Zoccai, B. W. Van Tassell and A. Abbate, Targeting the NLRP3 inflammasome in cardiovascular diseases; <em>Pharmacol. Ther</em>. <bold>236</bold> (2022) Article ID 108053; <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1016/j.pharmthera.2021.108053" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1016/j.pharmthera.2021.108053</a>">https://doi.org/10.1016/j.pharmthera.2021.108053</ext-link>
    Search in Google ScholarBack to article
  3. C. Pellegrini, A. Martelli, L. Antonioli, M. Fornai, C. Blandizzi and V. Calderone, NLRP3 inflamma-some in cardiovascular diseases: Pathophysiological and pharmacological implications, <em>Med. Res. Rev</em>. <bold>41</bold>(4) (2021) 1890–1926; <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1002/med.21781" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1002/med.21781</a>">https://doi.org/10.1002/med.21781</ext-link>
    Search in Google ScholarBack to article
  4. H. Y. Fang, X. N. Zhao, M. Zhang, Y. Y. Ma, J. L. Huang and P. Zhou, Beneficial effects of flavonoids on cardiovascular diseases by influencing NLRP3 inflammasome, <em>ŠĚ−ŒŒŸŽ’−łŒ−„ŸŁǯ</em> <bold>31</bold> (2023) 1715–1729; <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1007/s10787-023-01249-2" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1007/s10787-023-01249-2</a>">https://doi.org/10.1007/s10787-023-01249-2</ext-link>
    Search in Google ScholarBack to article
  5. J. P. Li, S. Qiu, G. J. Tai, Y. M. Liu, W. Wei, M. M. Fu, P. Q. Fang, J. N. Otieno, T. Battulga, X. X. Li and M. Xu, NLRP3 inflammasome-modulated angiogenic function of EPC via PI3K/Akt/mTOR pathway in diabetic myocardial infarction, <em>Cardiovasc. Diabetol</em>. <bold>24</bold> (2025) Article ID 6 (23 pages); <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1186/s12933-024-02541-3" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1186/s12933-024-02541-3</a>">https://doi.org/10.1186/s12933-024-02541-3</ext-link>
    Search in Google ScholarBack to article
  6. W. Zhou, C. Chen, Z. Chen, L. Liu, J. Jiang, Z. Wu, M. Zhao and Y. Chen, NLRP3: A novel mediator in cardiovascular disease, <em>J. Immunol. Res</em>. <bold>2018</bold> (2018) Article ID 5702103 (8 pages); <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1155/2018/5702103" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1155/2018/5702103</a>">https://doi.org/10.1155/2018/5702103</ext-link>
    Search in Google ScholarBack to article
  7. J. Fu and H. Wu, Structural mechanisms of NLRP3 inflammasome assembly and activation, <em>Annu. Rev. Immunol</em>. <bold>41</bold> (2023) 301–316; <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1146/annurev-immunol-081022-021207" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1146/annurev-immunol-081022-021207</a>">https://doi.org/10.1146/annurev-immunol-081022-021207</ext-link>
    Search in Google ScholarBack to article
  8. Y. Xie, G. Sun, Y. Tao, W. Zhang, S. Yang, L. Zhang, Y. Lu and G. Du, Current advances on the therapeutic potential of scutellarin: An updated review, <em>Nat. Prod. Bioprospect</em>. <bold>14</bold> (2024) Article ID 20 (15 pages); <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1007/s13659-024-00441-3" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1007/s13659-024-00441-3</a>">https://doi.org/10.1007/s13659-024-00441-3</ext-link>
    Search in Google ScholarBack to article
  9. Y. Zhou, C. Gu, Y. Zhu, Y. Zhu, Y. Chen, L. Shi, Y. Yang, X. Lu and H. Pang, Pharmacological effects and the related mechanism of scutellarin on inflammation-related diseases: A review, <em>Front Pharmacol.</em> <bold>15</bold> (2024) Article ID 1463140 (15 pages); <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.3389/fphar.2024.1463140" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3389/fphar.2024.1463140</a>">https://doi.org/10.3389/fphar.2024.1463140</ext-link>
    Search in Google ScholarBack to article
  10. X. Zhang, T. Yin, Y. Wang, J. Du, J. Dou and X. Zhang, Effects of scutellarin on the mechanism of cardiovascular diseases: A review, <em>Front. Pharmacol</em>. <bold>14</bold> (2024) Article ID 1329969 (19 pages); <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.3389/fphar.2023.1329969" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3389/fphar.2023.1329969</a>">https://doi.org/10.3389/fphar.2023.1329969</ext-link>
    Search in Google ScholarBack to article
  11. L. J. Xu, R. C. Chen, X. Y. Ma, Y. Zhu, G. B. Sun and X. B. Sun, Scutellarin protects against myocar-dial ischemia-reperfusion injury by suppressing NLRP3 inflammasome activation, <em>Phytomedicine</em> <bold>68</bold> (2020) Article ID Article ID 153169 (11 pages); <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1016/j.phymed.2020.153169" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1016/j.phymed.2020.153169</a>">https://doi.org/10.1016/j.phymed.2020.153169</ext-link>
    Search in Google ScholarBack to article
  12. H. Sharif, L. Wang, W. L. Wang, V. G. Magupalli, L. Andreeva, Q. Qiao, A. V. Hauenstein, Z. Wu, G. Núñez, Y. Mao and H. Wu, Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome, <em>Nature</em> <bold>570</bold> (2019) 338–343; <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1038/s41586-019-1295-z" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1038/s41586-019-1295-z</a>">https://doi.org/10.1038/s41586-019-1295-z</ext-link>
    Search in Google ScholarBack to article
  13. B. T. Fahr, T. O’Brien, P. Pham, N. D. Waal, S. Baskaran, B. C. Raimundo, J. W. Lam, M. M. Sopko, H. E. Purkey and M. J. Romanowski, Tethering identifies fragment that yields potent inhibitors of human caspase-1, <em>Bioorg. Med. Chem. Lett</em>. <bold>16</bold>(3) (2006) 559–562; <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1016/j.bmcl.2005.10.048" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1016/j.bmcl.2005.10.048</a>">https://doi.org/10.1016/j.bmcl.2005.10.048</ext-link>
    Search in Google ScholarBack to article
  14. S. Kuang, J. Zheng, H. Yang, S. Li, S. Duan, Y. Shen, C. Ji, J. Gan, X. W. Xu and J. Li, Structure insight of GSDMD reveals the basis of GSDMD autoinhibition in cell pyroptosis, <em>Proc. Natl. Acad. Sci. USA</em> <bold>114</bold>(40) (2017) 10642–10647. <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1073/pnas.1708194114" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1073/pnas.1708194114</a>">https://doi.org/10.1073/pnas.1708194114</ext-link>
    Search in Google ScholarBack to article
  15. Y. Liu, X. Yang, J. Gan, S. Chen, Z. X. Xiao and Y. Cao, CB-Dock2: Improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting, <em>Nucleic Acids Res</em>. <bold>50</bold>(W1) (2022) W159-W164; <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1093/nar/gkac394" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1093/nar/gkac394</a>">https://doi.org/10.1093/nar/gkac394</ext-link>
    Search in Google ScholarBack to article
  16. X. N. Zhao, H. M. Ding, Y. Y. Ma, L. Wang and P. Zhou, Ling-Gui-Zhu-Gan decoction inhibits cardiomyocyte pyroptosis via the NLRP3/Caspase-1 signaling pathway, <em>Tissue Cell</em>. <bold>91</bold> (2024) Article ID 102588; <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1016/j.tice.2024.102588" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1016/j.tice.2024.102588</a>">https://doi.org/10.1016/j.tice.2024.102588</ext-link>
    Search in Google ScholarBack to article
  17. X. Chen, Y. Li, J. Li, T. Liu, Q. Jiang, Y. Hong, Q. Wang, C. Li, D. Guo and Y. Wang, Qishen granule (QSG) exerts cardioprotective effects by inhibiting NLRP3 inflammasome and pyroptosis in myocardial infarction rats, <em>J. Ethnopharmacol</em>. <bold>285</bold> (2025) Article ID 114841; <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1016/j.jep.2021.114841" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1016/j.jep.2021.114841</a>">https://doi.org/10.1016/j.jep.2021.114841</ext-link>
    Search in Google ScholarBack to article
  18. Y. Qiu, Y. Huang, M. Chen, Y. Yang, X. Li and W. Zhang, Mitochondrial DNA in NLRP3 inflamma-some activation, <em>Int. Immunopharmacol</em>. <bold>108</bold> (2022) Article ID 108719; <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1016/j.intimp.2022.108719" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1016/j.intimp.2022.108719</a>">https://doi.org/10.1016/j.intimp.2022.108719</ext-link>
    Search in Google ScholarBack to article
  19. N. Kelley, D. Jeltema, Y. Duan and Y. He, The NLRP3 inflammasome: An overview of mechanisms of activation and regulation, <em>Int. J. Mol. Sci</em>. <bold>20</bold>(13) (2019) Article ID 3328 (24 pages); <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.3390/ijms20133328" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3390/ijms20133328</a>">https://doi.org/10.3390/ijms20133328</ext-link>
    Search in Google ScholarBack to article
  20. Y. Huang, W. Xu and R. Zhou, NLRP3 inflammasome activation and cell death, <em>Cell Mol. Immunol</em>. <bold>18</bold> (2021) 2114–2127; <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1038/s41423-021-00740-6" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1038/s41423-021-00740-6</a>">https://doi.org/10.1038/s41423-021-00740-6</ext-link>
    Search in Google ScholarBack to article
  21. A. Rauf, M. Shah, D. M. Yellon and S. M. Davidson, Role of caspase 1 in ischemia/reperfusion injury of the myocardium, <em>J. Cardiovasc. Pharmacol</em>. <bold>74</bold>(3) (2019) 194–200; <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1097/FJC.0000000000000694" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1097/FJC.0000000000000694</a>">https://doi.org/10.1097/FJC.0000000000000694</ext-link>
    Search in Google ScholarBack to article
  22. B. Zhang, G. Liu, B. Huang, H. Liu, H. Jiang, Z. Hu and J. Chen, KDM3A attenuates myocardial ischemic and reperfusion injury by ameliorating cardiac microvascular endothelial cell pyroptosis, <em>Oxid. Med. Cell Longev</em>. <bold>2022</bold> (2022) Article ID 4622520 (19 pages); <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1155/2022/4622520" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1155/2022/4622520</a>">https://doi.org/10.1155/2022/4622520</ext-link>
    Search in Google ScholarBack to article
  23. S. Toldo and A. Abbate, The NLRP3 inflammasome in acute myocardial infarction, <em>Nat. Rev. Cardiol.</em> <bold>15</bold> (2018) 203–214; <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1038/nrcardio.2017.161" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1038/nrcardio.2017.161</a>">https://doi.org/10.1038/nrcardio.2017.161</ext-link>
    Search in Google ScholarBack to article
  24. Y. S. Tang, Y. H. Zhao, Y. Zhong, X. Z. Li, J. X. Pu, Y. C. Luo and Q. L. Zhou, Neferine inhibits LPS-ATP-induced endothelial cell pyroptosis via regulation of ROS/NLRP3/Caspase-1 signaling pathway, <em>Inflamm. Res</em>. <bold>68</bold> (2019) 727–738. <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1007/s00011-019-01256-6" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1007/s00011-019-01256-6</a>">https://doi.org/10.1007/s00011-019-01256-6</ext-link>
    Search in Google ScholarBack to article
  25. E. L. Johnston, B. Heras, T. A. Kufer and M. Kaparakis-Liaskos, Detection of bacterial membrane vesicles by NOD-like receptors, <em>Int. J. Mol. Sci</em>. <bold>22</bold>(3) (2021) Article ID 1005 (14 pages); <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.3390/ijms22031005" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3390/ijms22031005</a>">https://doi.org/10.3390/ijms22031005</ext-link>
    Search in Google ScholarBack to article
  26. H. Kong, H. Zhao, T. Chen, Y. Song and Y. Cui, Targeted P2X7/NLRP3 signaling pathway against inflammation, apoptosis, and pyroptosis of retinal endothelial cells in diabetic retinopathy, <em>Cell Death Dis</em>. <bold>13</bold> (2022) Article ID 336 (13 pages); <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1038/s41419-022-04786-w" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1038/s41419-022-04786-w</a>">https://doi.org/10.1038/s41419-022-04786-w</ext-link>
    Search in Google ScholarBack to article
  27. S. Nie, S. Zhang, R. Wu, Y. Zhao, Y. Wang, X. Wang, M. Zhu and P. Huang, Scutellarin: Pharmacological effects and therapeutic mechanisms in chronic diseases, <em>Front Pharmacol</em>. <bold>15</bold> (2024) Article ID 1470879 (23 pages); <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.3389/fphar.2024.1470879" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3389/fphar.2024.1470879</a>">https://doi.org/10.3389/fphar.2024.1470879</ext-link>
    Search in Google ScholarBack to article
  28. J. K. Li, Z. P. Song and X. Z. Hou, Scutellarin ameliorates ischemia/reperfusion injury-induced cardiomyocyte apoptosis and cardiac dysfunction via inhibition of the cGAS-STING pathway, <em>Exp. Ther. Med</em>. <bold>25</bold>(4) (2023) Article ID 155 (9 pages); <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.3892/etm.2023.11854" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3892/etm.2023.11854</a>">https://doi.org/10.3892/etm.2023.11854</ext-link>
    Search in Google ScholarBack to article
  29. X. Fan, Y. Wang, X. Li, T. Zhong, C. Cheng and Y. Zhang, Scutellarin alleviates liver injury in type 2 diabetic mellitus by suppressing hepatocyte apoptosis <em>in vitro</em> and <em>in vivo</em>, <em>Chin. Herb Med</em>. <bold>15</bold>(4) (2023) 542–548; <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1016/j.chmed.2023.03.007" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1016/j.chmed.2023.03.007</a>">https://doi.org/10.1016/j.chmed.2023.03.007</ext-link>
    Search in Google ScholarBack to article
  30. L. Peng, L. Wen, Q. F. Shi, F. Gao, B. Huang, J. Meng, C. P. Hu and C. M. Wang, Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial-mesenchymal transition and inflammation, <em>Cell Death Dis</em>. <bold>11</bold> (2020) Article ID 978 (16 pages); <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1038/s41419-020-03178-2" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1038/s41419-020-03178-2</a>">https://doi.org/10.1038/s41419-020-03178-2</ext-link>
    Search in Google ScholarBack to article
  31. W. C. Gao, T. H. Yang, B. B. Wang, Q. Liu, Q. Li, Z. H. Zhou, C. B. Zheng and P. Chen, Scutellarin inhibits oleic acid induced vascular smooth muscle foam cell formation via activating autophagy and inhibiting NLRP3 inflammasome activation, <em>Clin. Exp. Pharmacol. Physiol</em>. <bold>51</bold>(4) (2024) e13845; <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1111/1440-1681.13845" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1111/1440-1681.13845</a>">https://doi.org/10.1111/1440-1681.13845</ext-link>
    Search in Google ScholarBack to article
  32. Z. Wang, P. Zhang, Y. Zhao, F. Yu, S. Wang, K. Liu, X. Cheng, J. Shi, Q. He, Y. Xia and L. Cheng, Scutellarin protects against mitochondrial reactive oxygen species-dependent NLRP3 inflamma-some activation to attenuate intervertebral disc degeneration, <em>Front. Bioeng. Biotechnol</em>. <bold>10</bold> (2022) Article ID 883118 (17 pages); <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.3389/fbioe.2022.883118" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3389/fbioe.2022.883118</a>">https://doi.org/10.3389/fbioe.2022.883118</ext-link>
    Search in Google ScholarBack to article
  33. H. T. Bian, G. H. Wang, J. J. Huang, L. Liang, L. Xiao, and H. L. Wang, Scutellarin protects against lipopolysaccharide-induced behavioral deficits by inhibiting neuroinflammation and microglia activation in rats, <em>Int. Immunopharmacol</em>. <bold>88</bold> (2020) Article ID106943 (7 pages); <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="<a href="https://doi.org/10.1016/j.intimp.2020.106943" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1016/j.intimp.2020.106943</a>">https://doi.org/10.1016/j.intimp.2020.106943</ext-link>
    Search in Google ScholarBack to article
DOI: https://doi.org/10.2478/acph-2025-0025 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 517 - 530
Accepted on: Jun 24, 2025
Published on: Oct 10, 2025
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
scutellarin,
LPS,
ATP,
NLRP3/caspase-1/GSDMD signalling pathway
Related subjects:
Pharmacy,
Pharmacy, other

© 2025 Xiao-Wei Li, Yun-Fei Chen, Lan Zhou, Peng Zhou, Peng Huang, Qian Niu, Jin-Cai Li, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 75 (2025): Issue 3 (September 2025)Next article